- Dr. Al-Holou speaking on: Subclonal Evolution of Resistant Cells in Glioblastoma: Identification and Therapeutic Implications
- Dr. Wahl speaking on: Linking altered GBM metabolism to treatment resistance in the lab and clinic


Zoom meeting
Contact Darla Kroft.
Daniel Wahl, MD, PhD and Wajd Al-Holou, MD